Hikma intros doxycycline for injection
Doxycycline for injection had a market value of approximately $43 million in the 12 months ended April 2021, according to IQVIA.
Hikma is rolling out doxycycline for injection in a dosage strength of 100 mg.
The product is an antibiotic indicated to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. It is used to treat various bacterial infections, including pneumonia and other respiratory tract infections.
Doxycycline for injection had a market value of approximately $43 million in the 12 months ended April 2021, according to IQVIA.